Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

  1. Home

  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Antiphospholipid Syndrome Poster
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0126: Performance of the 2023 and 2006 APS Classification Criteria in Pediatric Patients Diagnosed with APS: A Multisite Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Jacqueline A. Madison, MD – University of Michigan
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0129: Analysis of Antiphosphatidylserine/prothrombin Antibodies as a Predictor of Lupus Anticoagulant in the Pediatric Population
    Location: Hall F1
    Abstract Poster Presenter: Jonathan Marilao, MD – University of Texas Southwestern
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0127: Single-cell Profiling of Dermal Endothelial Cells Reveals Potential Cell-Cell Interactions in Patients with APS and a History of Cardiac Valve Disease
    Location: Hall F1
    Abstract Poster Presenter: Jason Knight, MD, PhD – University of Michigan
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0115: Dysfunctional Mitophagy Propels Neutrophil Hyperactivity and Thrombosis in Antiphospholipid Syndrome
    Location: Hall F1
    Abstract Poster Presenter: Ajay Tambralli, MD – University of Michigan
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0143: High-dimensional Spectral Flow Cytometry Reveals a Unique Distribution of Circulating B Cells in Patients with Antiphospholipid Syndrome
    Location: Hall F1
    Abstract Poster Presenter: Yuzhou Gan, MBBS – University of Michigan
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0140: Outcome Of Patients With Non-Criteria Manifestations Of Primary Antiphospholipid Syndrome Treated With Immunosuppressants -A Single Centre Study
    Location: Hall F1
    Abstract Poster Presenter: Sindhuja Rajendran, MBBS, MD, DM, MRCP – Christian Medical College, Vellore
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0134: Neutrophil Gasdermin D Pores as Potential Therapeutic Targets in APS-Associated Thromboinflammation
    Location: Hall F1
    Abstract Poster Presenter: NaveenKumar Somanathapura, PhD – University of Michigan
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0128: Defining a Consensus for Critical Data Fields for International Pediatric Antiphospholipid Syndrome Research
    Location: Hall F1
    Abstract Poster Presenter: Jheel Bhatt, MD – Advent Health Orlando
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0136: Beyond Thrombosis: Histological Spectrum, Predictors and Outcomes of Renal Involvement in Primary Antiphospholipid Syndrome: A Single-Centre Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Ritesh Kumar Mishra, MD – JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0123: Prognosis of Cardiac Involvement in Antiphospholipid Syndrome
    Location: Hall F1
    Abstract Poster Presenter: Gregory Pugnet, MD,PhD (he/him/his) – CHU Toulouse Rangueil Service de Medecine Interne et Immunologie Clinique
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0125: The IFN Signature is Less Pronounces in Primary Antiphospholipid Syndrome Compared with other Systemic Autoimmune Diseases
    Location: Hall F1
    Abstract Poster Presenter: Ioannis Parodis, MD, PhD – Karolinska Institutet and Karolinska University Hospital, Department of Medicine Solna, Division of Rheumatology
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0132: Increased Expression of Gas6 and Its Tyrosine Kinase Receptor Tyro3 Are Associated with Antiphospholipid Syndrome
    Location: Hall F1
    Abstract Poster Presenter: Liling Xu, PhD – Peking University People's Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0116: Cerebral small vessel disease in antiphospholipid syndrome: subtypes and total burden of cSVD on MRI
    Location: Hall F1
    Abstract Poster Presenter: Chun Li, n/a – Peking University People's Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0130: Plasminogen activator inhibitor 1 increases thrombotic risk in Antiphospholipid syndrome
    Location: Hall F1
    Abstract Poster Presenter: Koshy Thomas, MD, DM – Christian Medical College, Vellore
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0133: Differences in cardiovascular risk factor control between primary and systemic lupus erythematosus-related antiphospholipid syndrome in a multiethnic cohort of 1003 patients with antiphospholipid syndrome: the SUrvey of cardiovascular disease Risk Factors (SURF) in SLE and APS project
    Location: Hall F1
    Abstract Poster Presenter: Maria Tektonidou, PhD – National and Kapodistrian University of Athens
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0141: Cytokine profiles in antiphospholipid syndrome
    Location: Hall F1
    Abstract Poster Presenter: Xiangjun Liu, MBBS – Peking University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0131: Libman-Sacks Endocarditis in APS: A Case-Control Study of Clinical and Serologic Features
    Location: Hall F1
    Abstract Poster Presenter: Kyla Rodgers, MD, PhD – University of Michigan
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0118: Single-cell RNA sequencing of skin reveals vascular dysregulation in antiphospholipid syndrome
    Location: Hall F1
    Abstract Poster Presenter: Ecem Sevim, MD – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0142: Risk Factors for Antiphospholipid Syndrome-associated Nephropathy: A Retrospective Cohort Analysis
    Location: Hall F1
    Abstract Poster Presenter: Xiaohan Wei, n/a – Shanghai JiaoTong University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0124: Single-cell atlas reveals the central-and-peripheral immune remodeling mechanism and clinical benefits of talitacicept therapy in patients with primary antiphospholipid syndrome
    Location: Hall F1
    Abstract Poster Presenter: Haoyu Pan, MD – Department of Rheumatology and Immunology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0119: Thrombin Generation Assays Inform Hypercoagulability Mediated by Antiphospholipid Antibodies in Children with Systemic Lupus Erythematosus
    Location: Hall F1
    Abstract Poster Presenter: Elizabeth Sloan, MD – UT Southwestern
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0139: When One Isn't Enough: Does Adding IgM Worsen the Antiphospholipid Syndrome Phenotype?
    Location: Hall F1
    Abstract Poster Presenter: Santiago Dans Caballero, MD – H. U. Reina Sofía
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0117: Are Thrombotic or Obstetric Events Associated with Additional Clinical Domains in Triple Antiphospholypid Syndrome?
    Location: Hall F1
    Abstract Poster Presenter: Cristina Rocamora Gisbert, PhD – Universitat Autònoma de Barcelona
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0135: Rituximab in Antiphospholipid Syndrome: aPL Titer Decline and Clinical Outcomes
    Location: Hall F1
    Abstract Poster Presenter: Omer Uludag, MD – Istanbul Faculty of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0144: Duration of Anticoagulation in Antiphospholipid Antibody-positive Patients: Results from an AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Survey
    Location: Hall F1
    Abstract Poster Presenter: Zeynep Belce Erton, MD – Hospital for Special Surgery
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0122: The role of low profile antiphospholipid antibodies and adverse pregnancy outcomes.
    Location: Hall F1
    Abstract Poster Presenter: Eugenia Chock, MD – Yale School of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0120: The Prevalence and Clinical Significance of Heritable Thrombophilia in Antiphospholipid Antibody Positive Patients: Descriptive Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Registry
    Location: Hall F1
    Abstract Poster Presenter: Emre Sahin, MD – Hospital for Special Surgery
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0121: The Prevalence and Clinical Significance of IgA Anticardiolipin and Anti-β2-Glycoprotein-I Antibody Isotypes in Antiphospholipid Antibody Positive Patients: Descriptive Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Registry
    Location: Hall F1
    Abstract Poster Presenter: Emre Sahin, MD – Hospital for Special Surgery
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0138: Evaluating Artificial Intelligence for Diagnosing Antiphospholipid Syndrome in Pulmonary Embolism Case Reports: A Prompt-Based Analysis
    Location: Hall F1
    Abstract Poster Presenter: Sami Rabah, MD (he/him/his) – Lincoln Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0137: Landscape of Primary Antiphospholipid Syndrome: Clinical Spectrum, Serology, and Predictors of Damage in a Single Center Cohort of 233 Patients
    Location: Hall F1
    Abstract Poster Presenter: Ritesh Kumar Mishra, MD – JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH
  • Monday, Oct 27th
    10:00 AM - 11:30 AM Central Time
    27M21: Abstracts: Antiphospholipid Syndrome
    Location: W192A-C
    Abstract Moderator: Ali Duarte-Garcia, MD, MSc – Mayo Clinic
    Abstract Moderator: Jane Salmon, MD – Hospital for Special Surgery
     CE: 0.00
  • Monday, Oct 27th
    10:00 AM - 10:15 AM Central Time
    0855: Certolizumab Pegol to Prevent Adverse Pregnancy Outcomes in Patients with Antiphospholipid Syndrome and Lupus Anticoagulant (IMPACT): Results from Ongoing Recruitment of a Prospective, Single-Arm, Open-Label, Phase 2 Trial
    Location: W192A-C
    Presenting Author: Jane Salmon, MD – Hospital for Special Surgery
  • Monday, Oct 27th
    10:15 AM - 10:30 AM Central Time
    0856: Integrated Single-Cell and Spatial Transcriptomics Reveal Vascular and Immune Pathogenesis in APS Nephropathy
    Location: W192A-C
    Presenting Author: Hui Shi, MD, PhD – Shanghai Jiaotong University Affiliated Ruijin Hospital
  • Monday, Oct 27th
    10:30 AM - 10:45 AM Central Time
    0857: CD14-dependent MAP kinase signaling is required for pathogenic neutrophil extracellular trap formation in APS
    Location: W192A-C
    Presenting Author: Thalia Newman, BS (she/her/hers) – University of Michigan
  • Monday, Oct 27th
    10:45 AM - 11:00 AM Central Time
    0858: IgA Anti-β2GPI Antibodies Drive Proatherogenic Myeloid Activation and Vascular Dysfunction in APS
    Location: W192A-C
    Presenting Author: Kavya Sugur, PhD – Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor
  • Monday, Oct 27th
    11:00 AM - 11:15 AM Central Time
    0859: Trophoblast Dysfunction and Placental Alterations in a Mouse Model of Antiphospholipid Syndrome: The Potential Role of Neutrophil Extracellular Traps
    Location: W192A-C
    Presenting Author: Bruna Mazetto Fonseca, PhD (she/her/hers) – University of Michigan
  • Monday, Oct 27th
    11:15 AM - 11:30 AM Central Time
    0860: Activated Protein C Resistance and Protein C Antibodies in the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository
    Location: W192A-C
    Presenting Author: Doruk Erkan, MD, MPH – Hospital for Special Surgery